Sale of Strategic Investment in Jellagen

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that it has sold its stake in Jellagen Ltd (“Jellagen”) for approximately £215,000 in a private transaction. Jellagen is a private marine biotechnology company founded in 2013 focused on developing collagen biomaterials from jellyfish. Collagen Solutions had held a minority equity position in...